A Collaboration With Fresenius Kabi BioPharm

Discover how Fresenius Kabi BioPharm and Thermo Fisher Scientific are driving innovation in biosimilar development in an exclusive Q&A that highlights their collaborative efforts. Fresenius Kabi offers a deep dive into the complexities of cell culture and the strategies they've employed to overcome these challenges. They emphasize the critical role biosimilars play in expanding access to affordable healthcare and share their firsthand experience using Gibco™ Efficient-Pro™ Media. This advanced media solution has enabled them to meet stringent quality and productivity benchmarks, which demonstrates its value in high-performance biomanufacturing.